FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to ophthalmology. The invention characterises application of the double extrusion method to manufacture biodegraded implants fit for implantation in orbital so that at least 75% of particles of an active agent have diametre less than 10 or 20 micron, and a method of treating the pathological eye condition with used the produced biodegraded implant. The implants are made of mixed "СМГК" with hydrophilic and hydrophobic ends.
EFFECT: invention provides delivery of the active agents into the orbital area without sharp emission release.
15 cl, 10 tbl, 17 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR TREATING PATHOLOGY OF EYE BY MEANS OF IMPLANT WITH DURABLE DELIVERY OF DRUG SUBJECTS | 2014 |
|
RU2690841C1 |
| MULTILAYER BIODEGRADABLE OCULAR IMPLANT WITH DOSED DRUG RELEASE AND METHOD OF ITS MANUFACTURE | 2015 |
|
RU2620249C1 |
| BIODEGRADABLE DRUG DELIVERY SYSTEMS FOR LONG-TERM RELEASE OF PROTEIN | 2013 |
|
RU2676102C2 |
| METHOD OF TREATING ATROPHIC AGE-RELATED MACULAR DEGENERATION | 2009 |
|
RU2521338C9 |
| METHOD FOR TREATING ATROPHIC AGE RELATED MACULAR DEGENERATION | 2009 |
|
RU2668371C2 |
| INTRAOCULAR DRUG DELIVERY SYSTEMS | 2007 |
|
RU2440102C2 |
| INTRAOCULAR IMPLANTS CONTAINING PROSTAMIDES | 2014 |
|
RU2666603C2 |
| IMPLANT FOR PROLONGED DRUG DELIVERY | 2014 |
|
RU2641021C2 |
| MICROIMPLANTS FOR OPHTHALMOLOGIC INTRODUCTION | 2006 |
|
RU2357709C1 |
| INTRAOCULAR SYSTEMS OF SUSTAINED-RELEASE DRUG DELIVERY AND METHOD OF TREATING OPHTHALMIC DISEASES | 2010 |
|
RU2532333C2 |
